1018826-33-9

Basic information

• Product Name: 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)-methoxy)acetic acid
• Synonyms: 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)-methoxy)acetic acid
• CAS NO: 1018826-33-9
• Molecular Weight: 430.309
• Mol File: 1018826-33-9.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)-methoxy)acetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)-methoxy)acetic acid(1018826-33-9)
• EPA Substance Registry System: 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)-methoxy)acetic acid(1018826-33-9)

Safety Data

• Hazardous Substances Data: 1018826-33-9(Hazardous Substances Data)

Upstream product

• 4620-34-2 ethyl 1,2,3,4-tetrahydroquinoline-2-carboxylate 
• 1018826-31-7 [1-(3,4-dichloro-phenylsulfonyl)-1,2,3,4-tetrahydro-quinolin-2-yl]-methanol 
• 63430-96-6 1,2,3,4-tetrahydroquinolin-2-ylmethanol 
• 1018826-32-8 tert-butyl 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)methoxy)-acetate 

Relevant articles and documents

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives of the general formula (I'); processes for their preparation, medicaments containing these compounds, and the use of substituted sulfonamide derivatives for the preparation of medicaments

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.

SUBSTITUTED SULFONAMIDE COMPOUNDS

Substituted sulfonamide derivatives, a process for their preparation, pharmaceutical compositions containing these compounds, and to the use of substituted sulfonamide derivatives in the treatment or inhibition of pain and/or various disorders or disease states.